Leaflet HAEMOCOMPLETTAN P 1g powder for solution for injection / infusion

Indicated for: bleeding; coagulation disorders

Route of administration: injectable / infusion

Substance: human fibrinogen (anticoagulant)

ATC: B02BB01 (Blood and blood forming organs | Vitamin k and other hemostatics | Fibrinogen)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.


Human fibrinogen is an essential blood protein used as a medication to treat or prevent bleeding in patients with fibrinogen deficiency, a rare condition that can be congenital or acquired. Fibrinogen plays a crucial role in blood clotting, helping to form the clots needed to stop bleeding.

Human fibrinogen is administered by intravenous infusion under the strict supervision of medical personnel. The dose and frequency of administration are determined by the doctor, depending on the severity of the deficiency and the patient's needs. Careful monitoring is essential to prevent complications.

Possible side effects include allergic reactions, fever, chills, or an increased risk of blood clots. In rare cases, severe reactions such as anaphylactic shock may occur. If you experience any unusual symptoms, contact your doctor immediately.

Human fibrinogen is vital for patients with bleeding disorders, but its use requires careful medical supervision. Inform your doctor about any other conditions or treatments you are undergoing to reduce the risk of complications.

General data about HAEMOCOMPLETTAN P 1g

  • Substance: human fibrinogen
  • Date of latest medicines list: 01-06-2026
  • Product code: W13381003
  • Concentration: 1g
  • Pharmaceutical form: powder for solution for injection / infusion
  • Quantity: 1
  • Product type: Original
  • Price: 2405.72 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: CSL BEHRING GMBH - GERMANIA
  • Holder: CSL BEHRING GMBH - GERMANIA
  • Number: 7708/2015/01
  • Shelf life: 5 years

Compensation lists for HAEMOCOMPLETTAN P 1g CSL Behring

NHP 6.14 (C2) - Congenital afibrinogenemia

Price

Copayment

Patient

2405.72 RON

2405.72 RON

0.00 RON